|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1996-11-13
|
|
pubmed:abstractText |
Advanced glycation endproducts (AGEs) contribute to the pathogenesis of vascular complications in diabetes, aging and end-stage renal disease (ESRD). Immune abnormalities in patients with chronic renal failure and those treated by dialysis contribute to high rates of morbidity and mortality. We therefore sought a relationship between a circulating marker of immune dysfunction and plasma levels of the AGE pentosidine.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0301-0430
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
45
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
379-82
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:8793229-Arginine,
pubmed-meshheading:8793229-Biological Markers,
pubmed-meshheading:8793229-Biopterin,
pubmed-meshheading:8793229-Chromatography, High Pressure Liquid,
pubmed-meshheading:8793229-Cross-Linking Reagents,
pubmed-meshheading:8793229-Disease Progression,
pubmed-meshheading:8793229-Glycosylation End Products, Advanced,
pubmed-meshheading:8793229-Humans,
pubmed-meshheading:8793229-Kidney Failure, Chronic,
pubmed-meshheading:8793229-Lysine,
pubmed-meshheading:8793229-Monocytes,
pubmed-meshheading:8793229-Neopterin,
pubmed-meshheading:8793229-Peritoneal Dialysis,
pubmed-meshheading:8793229-Radioimmunoassay,
pubmed-meshheading:8793229-Renal Dialysis,
pubmed-meshheading:8793229-Uremia
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
The advanced glycation endproduct pentosidine and monocyte activation in uremia.
|
|
pubmed:affiliation |
Department of Medicine, Case-Western Reserve University, Cleveland, Ohio, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
